Observational Study
Copyright ©The Author(s) 2015.
World J Diabetes. Jul 10, 2015; 6(7): 983-989
Published online Jul 10, 2015. doi: 10.4239/wjd.v6.i7.983
Table 4 Changes in metabolic factors absolute monocyte CD36 expression pre and post administration of oral glucose
Circulating concentrations following the administration of glucose
P
0 min30 min120 min
Monocyte CD36 on Mon1 (Mon CD36+ per μL)300 (240, 324)223 (187, 254)353 (323, 382)< 0.001
Monocyte CD36 on Mon2 (Mon CD36+ per μL)23.9 (17.9, 32.3)21.3 (17.2, 30.8)29.9 (18.1, 39.6)0.011
Monocyte CD36 on Mon3 (Mon CD36+ per μL)36.7 (24.3, 53.2)26.1 (18.4, 45.8)34.4 (31.3, 48.7)0.03
Total monocyte CD36 (Mon CD36+ per μL)361 (308, 432)278 (240, 324)422 (394, 458)< 0.001
Plasma glucose (mmol/L)5.09 (4.5, 5.47)6.68 (4.93, 8.12)5.2 (4.64, 6.07)0.08
Serum NEFA (mmol/L)0.416 (0.264, 0.514)0.215 (0.098, 0.326)0.094 (0.071, 0.207)< 0.001
Serum cholesterol (mmol/L)3.41 (2.95, 3.96)3.29 (2.95, 3.95)3.44 (3.06, 3.80)0.52
Serum triglycerides (mmol/L)0.9 (0.67, 1.44)0.83 (0.55, 1.19)1.01 (0.54, 1.35)0.26
VLDL cholesterol (mmol/L)11.26 (0.97, 1.44)1.31 (0.94, 1.50)1.42 (1.27, 1.62)0.001
LDL cholesterol (mmol/L)11.39 (0.89, 1.71)1.61 (0.8, 1.82)1.92 (1.58, 2.24)0.003
HDL2 cholesterol (mmol/L)10.600 (0.425, 0.735)0.470 (0.360, 0.725)0.540 (0.415, 0.820)0.19
HDL3 cholesterol (mmol/L)10.395 (0.285, 0.505)0.330 (0.205, 0.450)0.325 (0.250, 0.570)0.43
VLDL triglyceride (mmol/L)10.338 (0.223, 0.440)0.263 (0.213, 0.365)0.265 (0.105, 0.353)0.37
LDL triglyceride (mmol/L)10.270 (0.170, 0.505)0.250 (0.170, 0.360)0.275 (0.125, 0.385)0.16
HDL2 triglyceride (mmol/L)10.080 (0.055, 0.138)0.070 (0.043, 0.093)0.060 (0.028, 0.100)0.09
HDL3 triglyceride (mmol/L)10.058 (0.035, 0.083)0.035 (0.013, 0.045)0.038 (0.025, 0.065)0.12
1Subfraction lipids. Data are median (interquartile range). NEFA: Non-esterified fatty acids; VLDL: Very low density lipoprotein; LDL: Low density lipoprotein; HDL: High density liporprotein.